TGFBR2 and colorectal carcinoma: Several markers, namely GALNS; GNAS;HIST1H1B; KRAS;MMP2;P2RY14;PHIP; RUNX1T1; SMAD2 and TGFBR2, showed different aberration profiles when compared to our previously published data with African American CRC patients (Table S4).